Orlistat for obesity management with high levels of TNFα in children

Authors

  • Arya Adi Bramasta Universitas Tarumanagara,Indonesia
  • Sri Deasy Aryeni Hadianto Universitas Tarumanagara, Indonesia
  • Thio Ceryle Eriady Universitas Tarumanagara, Indonesia
  • Michelle Ruth Natalie Universitas Tarumanagara, Indonesia
  • Nadya Putri Purwanto Universitas Tarumanagara, Indonesia

DOI:

https://doi.org/10.35335/midwifery.v11i1.1192

Keywords:

childhood obesity, obesity, TNFα and orlistat

Abstract

Childhood obesity has increased significantly over the past four decades. Obesity is the leading cause of preventable death in the world. An excess of body fat or adiposity characterizes it. TNFα expression in adipose tissue increases during the development of obesity. With the magnitude of the risk caused by obesity, efforts must be carried out to overcome obesity. Orlistat is a drug approved for obesity treatment in adolescents and children by the FDA. The data collection method was collected from articles related to orlistat in obesity management with high levels of TNFα in children. The inclusion criteria were from original articles, case-control studies, and review papers on childhood obesity, TNFα, and orlistat.  Orlistat is effective in obesity management with high levels of TNFα in children. Obesity is associated with low-level inflammatory processes in WAT. The increase in adipose tissue mass simultaneously activates inflammatory processes in WAT, located in the liver and immune cells. WAT is the source of several pro-inflammatory cytokines, mainly TNFα. The use of orlistat has been recognized as an effective way to lose weight in childhood obesity. Along with weight loss, a decrease in adipocytes reduces TNF α levels in children.

Downloads

Download data is not yet available.

References

Aldhoon Hainerová, I., & Lebl, J. (2013). Treatment options for children with monogenic forms of obesity. World Review of Nutrition and Dietetics, 106, 105–112. https://doi.org/10.1159/000342556

Campbell, M. K. (2016). Biological, environmental, and social influences on childhood obesity. In Pediatric Research (Vol. 79, Numbers 1–2, pp. 205–211). Nature Publishing Group. https://doi.org/10.1038/pr.2015.208

Cao, H. (2014). Adipocytokines in obesity and metabolic disease. In Journal of Endocrinology (Vol. 220, Number 2). https://doi.org/10.1530/JOE-13-0339

Chapman, S. (2021). Child and adolescent obesity. In Paediatrics and Child Health (United Kingdom) ( Vol. 31, Number 8, pp. 322–329). Churchill Livingstone. https://doi.org/10.1016/j.paed.2021.05.004

Cote, A. T., Harris, K. C., Panagiotopoulos, C., Sandor, G. G. S., & Devlin, A. M. (2013). Childhood obesity and cardiovascular dysfunction. In Journal of the American College of Cardiology (Vol. 62, No. 15, pp. 1309–1319). Elsevier USA. https://doi.org/10.1016/j.jacc.2013.07.042

Cunningham, S. A., Kramer, M. R., & Narayan, K. M. V. (2014). Incidence of Childhood Obesity in the United States. New England Journal of Medicine, 370(5), 403–411. https://doi.org/10.1056/nejmoa1309753

Dolinsky, D. H., Armstrong, S. C., & Kinra, S. (2013). The clinical treatment of childhood obesity. In Indian journal of pediatrics: Vol. 80 Suppl 1. https://doi.org/10.1007/s12098-012-0766-0

Ellulu, M. S., Patimah, I., Khaza'ai, H., Rahmat, A., & Abed, Y. (2017). Obesity & inflammation: The linking mechanism & the complications. Archives of Medical Science, 13(4), 851–863. https://doi.org/10.5114/aoms.2016.58928

Gazioglu, S. B., Akan, G., Atalar, F., & Erten, G. (2015). PAI-1 and TNF-α profiles of adipose tissue in obese cardiovascular disease patients. nt J Clin Exp Pathol , 8(12), 15919–15925.

Güngör, N. K. (2014). Overweight and obesity in children and adolescents. JCRPE Journal of Clinical Research in Pediatric Endocrinology, 6(3), 129–143. https://doi.org/10.4274/jcrpe.1471

Gurnani, M., Birken, C., & Hamilton, J. (2015). Childhood Obesity: Causes, Consequences, and Management. In Pediatric Clinics of North America (Vol. 62, Number 4, pp. 821–840). W.B. Saunders. https://doi.org/10.1016/j.pcl.2015.04.001

Hossain, M. A., Pervin, R., Debnath, D., & Bhuiyan, M. A. (2019). Therapeutic Treatment for Controlling Childhood Obesity. In Global Perspectives on Childhood Obesity (pp. 377–385). Elsevier. https://doi.org/10.1016/b978-0-12-812840-4.00030-x

Kelishadi, R., & Azizi-Soleiman, F. (2014). Controlling childhood obesity: A systematic review on strategies and challenges. In Journal of Research in Medical Sciences.

Kelsey, M. M., Zaepfel, A., Bjornstad, P., & Nadeau, K. J. (2014). Age-related consequences of childhood obesity. In Gerontology (Vol. 60, No. 3, pp. 222–228). S. Karger AG. https://doi.org/10.1159/000356023

Kose, M., Emet, S., Akplnar, T. S., Ilhan, M., Gok, A. F. K., Dadashov, M., & Tukek, T. (2015). An unexpected result of obesity treatment: Orlistat-related acute pancreatitis. Case Reports in Gastroenterology, 9, 152–155. https://doi.org/10.1159/000430433

Kumar, S., & Kelly, A. S. (2017). Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and Treatment. In Mayo Clinic Proceedings (Vol. 92, No. 2, pp. 251–265). Elsevier Ltd. https://doi.org/10.1016/j.mayocp.2016.09.017

Lee, H., Lee, I. S., & Choue, R. (2013). Obesity, inflammation and diet. In Pediatric Gastroenterology, Hepatology and Nutrition (Vol. 16, Number 3, pp. 143–152). Korean Society of Pediartic Gastroenterology, Hepatology and Nutrition. https://doi.org/10.5223/pghn.2013.16.3.143

Lenis, A. T., Lec, P. M., & Chamie, K. (2020). Bladder cancer a review. In JAMA - Journal of the American Medical Association (Vol. 324, Number 19, pp. 1980–1991). American Medical Association. https://doi.org/10.1001/jama.2020.17598

Liang, J., Matheson, B. E., Kaye, W. H., & Boutelle, K. N. (2014). Neurocognitive correlates of obesity and obesity-related behaviors in children and adolescents. International Journal of Obesity, 38(4), 494–506. https://doi.org/10.1038/ijo.2013.142

Llewellyn, A., Simmonds, M., Owen, C. G., & Woolacott, N. (2016). Childhood obesity as a predictor of morbidity in adulthood: A systematic review and meta-analysis. Obesity Reviews, 17(1), 56–67. https://doi.org/10.1111/obr.12316

Makki, K., Froguel, P., & Wolowczuk, I. (2013). Adipose Tissue in Obesity-Related Inflammation and Insulin Resistance: Cells, Cytokines, and Chemokines. ISRN Inflammation, 2013, 1–12. https://doi.org/10.1155/2013/139239

Marques, P. (2015). Management of Pediatric Obesity. Journal of Diabetes, Metabolic Disorders & Control, 2(1). https://doi.org/10.15406/jdmdc.2015.02.00027

Nakamura, K., Fuster, J. J., & Walsh, K. (2014). Adipokines: A link between obesity and cardiovascular disease. In Journal of Cardiology (Vol. 63, Number 4, pp. 250–259). Japanese College of Cardiology (Nippon-Sinzobyo-Gakkai). https://doi.org/10.1016/j.jjcc.2013.11.006

Ohashi, K., Shibata, R., Murohara, T., & Ouchi, N. (2014). Role of anti-inflammatory adipokines in obesity-related diseases. In Trends in Endocrinology and Metabolism (Vol. 25, Number 7, pp. 348–355). Elsevier Inc. https://doi.org/10.1016/j.tem.2014.03.009

Othman, Z. A., Zakaria, Z., Suleiman, J. B., Ghazali, W. S. W., & Mohamed, M. (2021). Anti-atherogenic effects of orlistat on obesity-induced vascular oxidative stress rat model. Antioxidants, 10(2), 1–16. https://doi.org/10.3390/antiox10020251

Pandita, A., Sharma, D., Pandita, D., Pawar, S., Tariq, M., & Kaul, A. (2016). Childhood obesity: Prevention is better than cure. In Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy (Vol. 9, pp. 83–89). Dove Medical Press Ltd. https://doi.org/10.2147/DMSO.S90783

Pulgarón, E. R. (2013). Childhood Obesity: A Review of Increased Risk for Physical and Psychological Comorbidities. In Clinical Therapeutics (Vol. 35, Number 1). https://doi.org/10.1016/j.clinthera.2012.12.014

Qi, X. (2018). Review of the Clinical Effect of Orlistat. IOP Conference Series: Materials Science and Engineering, 301(1). https://doi.org/10.1088/1757-899X/301/1/012063

Rajjo, T., Mohammed, K., Alsawas, M., Ahmed, A. T., Farah, W., Asi, N., Almasri, J., Prokop, L. J., & Murad, M. H. (2017). Treatment of pediatric obesity: An umbrella systematic review. In Journal of Clinical Endocrinology and Metabolism (Vol. 102, Number 3, pp. 763–775). Endocrine Society. https://doi.org/10.1210/jc.2016-2574

Reilly, S. M., & Saltiel, A. R. (2017). Adapting to obesity with adipose tissue inflammation. In Nature Reviews Endocrinology (Vol. 13, Number 11, pp. 633–643). Nature Publishing Group. https://doi.org/10.1038/nrendo.2017.90

Rivera, J. ÃÂÂ., De Cossío, T. G., Pedraza, L. S., Aburto, T. C., Sánchez, T. G., & Martorell, R. (2014). Childhood and adolescent overweight and obesity in Latin America: A systematic review. In The Lancet Diabetes and Endocrinology (Vol. 2, Number 4, pp. 321–332). Elsevier Limited. https://doi.org/10.1016/S2213-8587(13)70173-6

Rodríguez-Hernández, H., Simental-Mendía, L. E., Rodríguez-Ramírez, G., & Reyes-Romero, M. A. (2013). Obesity and inflammation: Epidemiology, risk factors, and markers of inflammation. In International Journal of Endocrinology (Vol. 2013). https://doi.org/10.1155/2013/678159

Sahoo, K., Sahoo, B., Choudhury, A., Sofi, N., Kumar, R., & Bhadoria, A. (2015). Childhood obesity: causes and consequences. Journal of Family Medicine and Primary Care, 4(2), 187. https://doi.org/10.4103/2249-4863.154628

Salem, Z., & Rezaeian, M. (2012). Drug Therapy in Obese Adolescents. In Zahedan Journal of Research in Medical Sciences Journal.

Seo, M. J., Lee, Y. J., Hwang, J. H., Kim, K. J., & Lee, B. Y. (2015). The inhibitory effects of quercetin on obesity and obesity-induced inflammation by regulation of MAPK signaling. Journal of Nutritional Biochemistry, 26(11), 1308–1316. https://doi.org/10.1016/j.jnutbio.2015.06.005

Stępień, M., Stępień, A., Wlazeł, R. N., Paradowski, M., Banach, M., & Rysz, J. (2014). Obesity indices and inflammatory markers in obese non-diabetic normo-and hypertensive patients: a comparative pilot study.

Tateya, S., Kim, F., & Tamori, Y. (2013). Recent advances in obesity-induced inflammation and insulin resistance. In Frontiers in Endocrinology (Vol. 4, AUG Number). https://doi.org/10.3389/fendo.2013.00093

Viner, R. M., Kinra, S., Christie, D., Cole, T. J., Costa, S., Croker, H., Fry, T., Hsia, Y., Hudson, L., Kessel, A. S., Morris, S., Nazareth, I., Nicholls, D., Park, M. H., Saxena, S., Taylor, B., White, B., & Wong, I. C. (2020). Improving the assessment and management of obesity in UK children and adolescents: the PROMISE research programme including a RCT. Programme Grants for Applied Research, 8(3), 1–264. https://doi.org/10.3310/pgfar08030

Wright, N., & Wales, J. (2016). Assessment and management of severely obese children and adolescents. Archives of Disease in Childhood, 101(12), 1161–1167. https://doi.org/10.1136/archdischild-2015-309103

Xu, S., & Xue, Y. (2016). Pediatric obesity: Causes, symptoms, prevention and treatment (review). In Experimental and Therapeutic Medicine (Vol. 11, Number 1, pp. 15–20). Spandidos Publications. https://doi.org/10.3892/etm.2015.2853

Zelová, H., & Hošek, J. (2013). TNF-α signalling and inflammation: Interactions between old acquaintances. In Inflammation Research (Vol. 62, No. 7, pp. 641–651). https://doi.org/10.1007/s00011-013-0633-0

Downloads

Published

2023-05-03

How to Cite

Adi Bramasta, A. (2023) “Orlistat for obesity management with high levels of TNFα in children ”, Science Midwifery, 11(1), pp. 244–250. doi: 10.35335/midwifery.v11i1.1192.

Issue

Vol. 11 No. 1 (2023): April: Midwifery and Health Sciences

Section

Articles